Skip to main content
Premium Trial:

Request an Annual Quote

Agencourt Plans to Beef Up Its Reagents Profile

BOSTON, Oct. 3 - Agencourt Bioscience is in the process of expanding its reagents business, a company official told GenomeWeb today.


Mann Shoffner, senior manager of marketing and business development at Agencourt, said the company is "identifying new market opportunities" within the reagent market. He also said the company is looking to hire an undisclosed number of R&D researchers to support the effort.


"There's a whole list of new purification needs in the market today," Shoffner said here at TIGR's 2002 annual GSAC meeting. "We are beefing up our effort here." He declined to elaborate.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.